Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry
MYTH: We only fill individual prescriptions, not bulk orders. REALITY: The FDA has stated that it does not intend to take action against a compounder for compounding a drug product that is essentially a copy of a commercially available drug product regularly or in inordinate amounts if the compounder fills four or fewer prescriptions for the relevant compounded drug product in a calendar month
You may be a candidate if you have: BMI 27 kg/m with obesity-related health problems BMI 30 kg/m Type 2 diabetes with overweight Fatty liver disease PCOS with obesity Sleep apnea High blood pressure Difficulty losing weight despite lifestyle changes A complete medical evaluation is essential before starting treatment
You cannot change your dose earlier
Rats fed oligofructose, a substrate for the colonic microbiota which leads to higher SCFAs levels, possess an increased number of colonic L-cells (397)
My body needed the GLP-1 and clinical support," said Williams